theoccurrence diastaseresistant inclusion bodies hepatocytes used marker heterozygous pi mz deficiency order study frequency lung liver malignant disease consecutive autopsy material defined population typical inclusion bodies liver NUMBER NUMBER NUMBER cases studied NUMBER subjects liver cirrhosis fibrosis lung disease emphysema significantly prevalent p NUMBER controls prevalence malignant disease did differ groups results consistent concept heterozygous pi mz deficiency predisposes liver lung disease does influence survival rate pas positive alpha1 antitrypsin pas positive pas negative alpha1 antitrypsin